Telomir Pharmaceuticals, Inc. Common Stock ( TELO) - Key Metrics
TELO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.05 | -$0.03 | -$0.03 |
| 2026Q1 | $0 | -$0.03 | -$0.05 | -$0.05 |
| 2025Q4 | $0 | -$0.06 | -$0.03 | -$0.03 |
| 2025Q3 | $0 | -$0.04 | -$0.03 | -$0.03 |
| 2025Q2 | $0 | -$0.17 | -$0.02 | -$0.02 |
TELO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.23 |
| 2026Q1 | 0% | -10.83 |
| 2025Q4 | 0% | -5.54 |
| 2025Q3 | 0% | -10.22 |
| 2025Q2 | 0% | -1.84 |
TELO
Price: $1.05
52 week price:
Earnings Per Share: -1.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 81.2 million